Research on menopause treatments is ongoing, with some outlets reporting on advances in non-hormonal therapies for vasomotor symptoms. However, other reports focus on hormone replacement therapy, with some indicating that it may not increase cardiovascular disease risk in certain women, while others discuss changes to FDA warnings and labeling for these therapies. The status of hormone therapy for menopause symptoms appears to be evolving, with various studies and updates being released.